Assessment of patients affected by rheumatoid arthritis eligible for biotechnological agents and evaluation of their healthcare resource utilization and related costs
Submitted: 1 August 2020
Accepted: 15 February 2021
Published: 19 April 2021
Accepted: 15 February 2021
Abstract Views: 3469
PDF: 486
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- S. Russo, T. T. Mariani, R. Migliorini, A. Marcellusi, F. S. Mennini, The economic burden of musculoskeletal disorders on the Italian social security pension system estimated by a Monte Carlo simulation , Reumatismo: Vol. 67 No. 2 (2015)
- G. Lapadula, A. Marchesoni, F. Salaffi, R. Ramonda, C. Salvarani, L. Punzi, L. Costa, F. Caso, D. Simone, G. Baiocchi, C. Scioscia, M. Di Carlo, R. Scarpa, G. Ferraccioli, Evidence-based algorithm for diagnosis and assessment in psoriatic arthritis: results by Italian DElphi in psoriatic Arthritis (IDEA) , Reumatismo: Vol. 68 No. 3 (2016)
- L. Degli Esposti, L. Sinigaglia, M. Rossini, S. Adami, C. Cagnoni, C. Magliaro, C. Veronesi, S. Buda, S. Minisola, Adherence to therapeutic and diagnostic recommendations in patients with femur fracture and at risk of re-fracture or death: results of an analysis of administrative databases , Reumatismo: Vol. 64 No. 1 (2012)
- M. Tofani, M. Nobilia, G. Culicchia, G. Esposito, A. Savona, I. Tashi, A. Ventura, G. Galeoto, The Italian version of rheumatoid arthritis pain scale (IT-RAPS): psychometric properties on community and clinical samples , Reumatismo: Vol. 71 No. 1 (2019)
- M. Rossini, O. Viapiana, M. Vitiello, N. Malavolta, G. La Montagna, S. Maddali Bongi, O. Di Munno, R. Nuti, C.U. Manzini, C. Ferri, L. Bogliolo, A. Mathieu, F. Cantatore, A. Del Puente, M. Muratore, W. Grassi, B. Frediani, G. Saviola, P. Delvino, L. Mirone, G. Ferraccioli, G. Tripi, I. Piazza, D. Gatti, Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study , Reumatismo: Vol. 69 No. 1 (2017)
- S.M. Gamal, A.K. Alkemary, M.A. Abdo, A.H.M. El Dakrony, Low body mass index in long standing rheumatoid arthritis: relation to RA disease activity and functional indices , Reumatismo: Vol. 70 No. 2 (2018)
- G. Cafaro, A. Alunno, V. Valentini, M.C. Leone, E. Marcucci, E. Bartoloni, R. Gerli, The onset site of rheumatoid arthritis: the joints or the lung? , Reumatismo: Vol. 68 No. 4 (2016)
- C. Chatzigeorgiou, S.L. Mackie, Comorbidity in polymyalgia rheumatica , Reumatismo: Vol. 70 No. 1 (2018): Monographic issue on Polymyalgia Rheumatica
- G. Pasero, P. Marson, A short history of anti-rheumatic therapy - VI. Rheumatoid arthritis drugs , Reumatismo: Vol. 63 No. 2 (2011)
- M. Rossini, O Viapiana, G. Orsolini, E. Fracassi, L. Idolazzi, D. Gatti, S. Adami, M. Govoni, Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis? , Reumatismo: Vol. 66 No. 4 (2014)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
You may also start an advanced similarity search for this article.